Structured Product Labeling (SPL) HT9426-26-Q-E022

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ARMY MED RES ACQ ACTIVITY

Contract Value

Not provided

Codes & Classification
Solicitation Number

PANDHA-26-P-0000035401

NAICS

541690 - Other Scientific and Technical Consulting Services

Classification Code

R408

Additional Details
Set Aside

NONE

Place of Performance

Frederick, Maryland, UNITED STATES

SourceSAM
The Defense Health Agency (DHA), under the Department of Defense and represented by the Army Medical Research Acquisition Activity (MRDC), has issued a combined synopsis/solicitation for Structured Product Labeling (SPL) services, identified by procurement number PANDHA-26-P-0000035401 and SAM.gov Opportunity ID e923d4da864046738336d97877b911aa. This requirement is managed by the Office of Regulated Activities within the DHA R&D – Medical Research and Development Command (MRDC), with the place of performance specified as Frederick, Maryland. The primary purpose of this procurement is to secure expert support for managing, processing, and completing both initial and ongoing labeling changes for electronic structured product label document submissions to the U.S. Food and Drug Administration (FDA). SPL is a Health Level Seven (HL7) standard, based on Clinical Document Architecture and the HL7 Reference Information Model (RIM), and is accredited by the American National Standards Institute (ANSI). It is essential for the exchange of product information in a standardized electronic format. The DHA R&D – MRDC currently holds two licensed New Drug Application (NDA) products, both of which require SPL submissions covering up to five levels of primary and secondary labeling. The scope of work encompasses the full lifecycle of SPL document management, including initial creation, updates, and regulatory submissions to the FDA. Contractors are expected to demonstrate proficiency in the HL7 SPL standard, familiarity with FDA submission protocols, and the ability to handle complex labeling requirements for pharmaceutical products. Deliverables will include accurate, compliant SPL documents for both initial and subsequent labeling changes, ensuring timely and successful FDA submissions for the MRDC’s NDA products. This opportunity is classified under NAICS code 541690 (Other Scientific and Technical Consulting Services), with the 2022 version year, and product service code R408. There are no set-aside requirements, making this solicitation open to all qualified vendors. The contracting entity is the Army Medical Research Acquisition Activity, a federal office within the Defense Health Agency. Interested parties should note the following key contacts for this procurement: Matthew Gembe ([email protected], 301-619-1350) as the primary point of contact, and Terrie Bloom ([email protected]) as the contracting officer. The solicitation was posted on June 29, 2026, and responses are due by July 1, 2026. Contractors evaluating this opportunity should ensure their capabilities align with the technical requirements for SPL document preparation and FDA submission processes, as well as their ability to support ongoing regulatory compliance for pharmaceutical labeling. The contract will be performed in Frederick, Maryland, and will remain under the oversight of the Army Medical Research Acquisition Activity throughout its lifecycle. For further details and access to solicitation attachments, interested vendors are encouraged to visit the official notice at https://sam.gov/opp/e923d4da864046738336d97877b911aa/view.
Documents8